Summary
Johnson & Johnson (JNJ) filed an 8-K on October 17, 2023, to announce its third-quarter financial results for the period ended October 1, 2023. The filing primarily references a press release (Exhibit 99.1) and supplementary financial data (Exhibit 99.2) detailing sales and earnings for the quarter and the year-to-date period. Investors should review the referenced exhibits for specific performance metrics, including revenue growth across segments and profitability. This report serves as the official notification of the company's latest financial performance, setting the stage for investor analysis and potential market reactions.
Key Highlights
- 1Johnson & Johnson filed an 8-K on October 17, 2023, reporting its Q3 2023 financial results.
- 2The primary information is contained within an attached press release (Exhibit 99.1).
- 3Supplementary unaudited comparative sales data and condensed consolidated statements of earnings are also provided (Exhibit 99.2).
- 4The reporting period covers the third quarter ended October 1, 2023, and the nine months ended on the same date.
- 5Investors should refer to the referenced exhibits for detailed sales and earnings performance.
- 6The filing indicates the company's financial performance update for the most recent quarter.